Abstract
Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Keywords: Serotonin7 Receptors, amino acid
Current Medicinal Chemistry
Title: Serotonin7 Receptors (5-HT7Rs)and their Ligands
Volume: 11 Issue: 5
Author(s): M. Leopoldo
Affiliation:
Keywords: Serotonin7 Receptors, amino acid
Abstract: Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Export Options
About this article
Cite this article as:
Leopoldo M., Serotonin7 Receptors (5-HT7Rs)and their Ligands, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455828
DOI https://dx.doi.org/10.2174/0929867043455828 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Molecular Bridge: Connecting Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Genomic and Molecular Characterization of Alzheimer Disease
Current Psychiatry Reviews A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
Current Cancer Drug Targets Sensitivity of Different MRI-Techniques to Assess Gray Matter Atrophy Patterns in Alzheimer’s Disease is Region-Specific
Current Alzheimer Research Extracorporeal Shock Wave Therapy for Calcific Tendonitis of the Rotator Cuff: A Review
Current Rheumatology Reviews Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes
Current Topics in Medicinal Chemistry Restoration of the Immune Balance by Autologous Bone Marrow Transplantation in Juvenile Idiopathic Arthritis
Current Stem Cell Research & Therapy Different Inductive Effects of Praziquantel Racemate and its Enantiomers on the Enzyme CYP3A4 Mediated by Pregnane X Receptor and its Variants
Current Drug Metabolism Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Editorial [Hot-Topic:Physical and Chemical Agents Inducing Cell Death and Differentiation (Executive Editor: Roberta Di Pietro)]
Current Pharmaceutical Design Role of HIF-1 in Iron Regulation: Potential Therapeutic Strategy for Neurodegenerative Disorders
Current Molecular Medicine The Role of CD8+ T Cells in Multiple Sclerosis and its Animal Models
Current Drug Targets - Inflammation & Allergy Assay of Biogenic Monoamines in Milk by Fluorescence-LC Following Derivatization with Naphthalene-2,3-dicarboxaldehyde
Current Analytical Chemistry The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms and Approaches to Treatment
Current Pharmaceutical Design Pharmacokinetic Concepts Revisited - Basic and Applied
Current Pharmaceutical Biotechnology Substituted Urea Derivatives: A Potent Class of Antidepressant Agents
Medicinal Chemistry New Potential Biologically Active Compounds: Synthesis and Characterization of Urea and Thiourea Derivativpes Bearing 1,2,4-oxadiazole Ring
Current Organic Synthesis Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry Cancer Cachexia: One Step Ahead
Reviews on Recent Clinical Trials Substance Abuse, HIV-1 and Hepatitis
Current HIV Research